|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 701 PENNSYLVANIA AVENUE, N.W., SUITE 800 |
Address2 | |
| City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 17831-12
|
||||||||
|
6. House ID# 310010000
|
||||||||
| TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Brett Loper, Senior Executive Vice President and Director, Government Affairs |
Date | 01/21/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 1321/S 2404 - Medicare Advanced Laboratory Diagnostics Act of 2007 - a bill to improve payments under the Medicare clinical laboratory fee schedule. [Julie Cohen, Elizabeth Pika Sharp]
S. 2029/HR 5605 - Physician Payments Sunshine Act of 2007 - a bill to provide transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP. [Julie Cohen, Brett Loper, Elizabeth Kegler]
S. 2221 - Transparency in Medical Device Pricing Act of 2007 - a bill to provide for the reporting of sales prices data for implantable medical devices [Brett Loper, Elizabeth Kegler]
HR 5765 - Medicare Remote Monitoring Access Act of 2008 - to amend Title XVIII of the Social Security Act to cover remote patient management services for certain chronic health conditions under the Medicare Program. [Julie Cohen, Elizabeth Kegler]
HR 6761 - to require the Secretary of Health and Human Services to enter into negotiated rulemaking to modernize the Medicare Part B fee schedule for clinical diagnostic laboratory tests. [Elizabeth Pika Sharp]
S. 3408 - Comparative Effectiveness Research Act of 2008 - A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes. [Julie Cohen, Elizabeth Kegler, Brett Loper]
H.R. 6163 - To improve the provision of telehealth services under the Medicare Program, to provide grants for the development of telehealth networks,, and for other purposes. [Julie Cohen, Elizabeth Pika Sharp]
* Gainshairing - No specific bill - a provision in the proposed 2009 Physician Fee Schedule regulation [Julie Cohen, Elizabeth Kegler, Brett Loper]
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Julie |
Cohen |
|
|
|
Elizabeth |
Pika Sharp |
|
|
|
Elizabeth |
Kegler |
|
|
|
Brett |
Loper |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
HR 1424 - Emergency Economic Stabilization Act - a bill to provide authority for the Federal Government to purchase and insure certain types of troubled assets for the purposes of providing stability to and preventing disruption in the economy and financial system and protecting taxpayers, to amend the Internal Revenue Code of 1986 to provide incentives for energy production and conservation, to extend cetain expiring provisions, to provide individual income tax relief, and for other purposes. [Brett Loper]
Stimulus Package - No Specific Bill - A tax provision regarding net operating losses. [Elizabeth Pika Sharp]
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brett |
Loper |
|
|
|
Elizabeth |
Pika Sharp |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 6381/S. 3398 - to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices. [Julie Cohen, Brett Loper, Elizabeth Pika Sharp, Elizabeth Kegler]
HR 1014/S. 573 - To amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women. [Brett Loper, Elizabeth Pika Sharp]
* Direct to Consumer advertising of medical devices - No specific bill - [Julie Cohen, Leah Kegler, Brett Loper]
* Import Safety - S. 3409/(No Specific House bill) - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration.[Brett Loper, Elizabeth Pika Sharp]
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Julie |
Cohen |
|
|
|
Brett |
Loper |
|
|
|
Elizabeth |
Kegler |
|
|
|
Elizabeth |
Pika Sharp |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |